Your browser doesn't support javascript.
loading
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.
Green, Sabrina I; Clark, Justin R; Santos, Haroldo H; Weesner, Kyle E; Salazar, Keiko C; Aslam, Saima; Campbell, J William; Doernberg, Sarah B; Blodget, Emily; Morris, Michele I; Suh, Gina A; Obeid, Karam; Silveira, Fernanda P; Filippov, Andrey A; Whiteson, Katrine L; Trautner, Barbara W; Terwilliger, Austen L; Maresso, Anthony.
Afiliação
  • Green SI; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Clark JR; Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.
  • Santos HH; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Weesner KE; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Salazar KC; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Aslam S; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Campbell JW; Division of Infectious Diseases and Global Public Health, Center for Innovative Phage Applications and Therapeutics, University of California, San Diego, La Jolla, California, USA.
  • Doernberg SB; Division of Infectious Diseases and Infection Prevention, St. Luke's Hospital, Chesterfield, Missouri, USA.
  • Blodget E; Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Morris MI; Department of Medicine, University of California, Irvine, California, USA.
  • Suh GA; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Obeid K; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Silveira FP; Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Filippov AA; Division of Infection Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Whiteson KL; Wound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
  • Trautner BW; Department of Molecular Biology and Biochemistry, University of California, Irvine, California, USA.
  • Terwilliger AL; Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
  • Maresso A; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Clin Infect Dis ; 77(8): 1079-1091, 2023 10 13.
Article em En | MEDLINE | ID: mdl-37279523
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Bacteriófagos / Terapia por Fagos Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Bacteriófagos / Terapia por Fagos Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article